Evidence map›Paper›PMID 33572124›Full record

ArticleBiomolecules2021

Effect of

Morgane Bourmaud, Mylene Zarka, Romain Le Cozannet, Pascale Fança-Berthon, Eric Hay, Martine Cohen-Solal

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomolecules, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Morgane BourmaudBIOSCAR Inserm U1132, Department of Rheumatology, Université de Paris, Hôpital Lariboisière, F-75010 Paris, France.
Mylene ZarkaBIOSCAR Inserm U1132, Department of Rheumatology, Université de Paris, Hôpital Lariboisière, F-75010 Paris, France.ORCID 0000-0003-3179-4432
Romain Le CozannetNaturex, Part of Givaudan SA, 250 rue Pierre Bayle, 84000 Avignon, France.
Pascale Fança-BerthonNaturex, Part of Givaudan SA, 250 rue Pierre Bayle, 84000 Avignon, France.
Eric HayBIOSCAR Inserm U1132, Department of Rheumatology, Université de Paris, Hôpital Lariboisière, F-75010 Paris, France.
Martine Cohen-SolalBIOSCAR Inserm U1132, Department of Rheumatology, Université de Paris, Hôpital Lariboisière, F-75010 Paris, France.ORCID 0000-0002-8582-8258
Inserm · FRGivaudan (France) · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoarthritis is characterized by cartilage loss resulting from the activation of chondrocytes associated with a synovial inflammation. Activated chondrocytes promote an increased secretion of matrix proteases and proinflammatory cytokines leading to cartilage breakdown. Since natural products possess anti-inflammatory properties, we investigated the direct effect of

Indexed as

AnimalsChondrocytesDose-Response Relationship, DrugGene Expression RegulationInflammation MediatorsMacrophagesMicePlant ExtractsRAW 264.7 CellsRubusInflammation MediatorsPlant ExtractschondrocytesinflammationmacrophagesosteoarthritisRubus idaeus

Identifiers

PMID33572124
PMCPMC7915036
OpenAlexW3128863097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.